• Image of ULTOMIRIS medication Image of ULTOMIRIS medication
    • ULTOMIRIS

    • QTY 33
    • 1100 MG/11
    • VIAL
    • Near  77381

RAVULIZUMAB (rav ue LIZ ue mab) treats autoimmune conditions that cause low levels of red blood cells (anemia) and blood clots, such as atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). It may also be used to treat autoimmune conditions that affect the nervous system, such as neuromyelitis optica and myasthenia gravis. It works by slowing down an overactive immune system. It is a monoclonal antibody.


ULTOMIRIS Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.